{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:56:51Z","timestamp":1790704611186,"version":"4.1.0"},"reference-count":57,"publisher":"IMR Press","issue":"9","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br. J. Hosp. Med. (Lond)"],"abstract":"<jats:p>Gastrointestinal (GI) involvement is among the most common and clinically important manifestations of systemic sclerosis (SSc), affecting up to 90% of patients and substantially contributing to morbidity and reduced quality of life. SSc-related GI disease results from microvascular injury, enteric nervous system dysfunction, and progressive smooth muscle atrophy with fibrosis, producing widespread dysmotility throughout the gastrointestinal tract. Clinical involvement can extend from the oral cavity to the anorectum, with esophageal dysfunction, gastroesophageal reflux disease (GERD), gastroparesis, small intestinal bacterial overgrowth (SIBO), and intestinal pseudo-obstruction among the major manifestations. Recent diagnostic advances, including high-resolution esophageal manometry (HRM), ambulatory pH-impedance monitoring, and improved imaging, have strengthened early detection and characterization of GI involvement. Treatment remains largely supportive and symptom-directed, including acid suppression, prokinetic therapy, nutritional optimization, and endoscopic or surgical management of complications. Growing evidence on the gut microbiome, immune-mediated mechanisms, and the gut-brain axis is expanding understanding of disease pathophysiology and may guide future targeted therapies. This review synthesizes current evidence on the epidemiology, pathophysiology, clinical manifestations, and management of gastrointestinal involvement in systemic sclerosis, emphasizing early recognition and multidisciplinary care. We conclude by outlining persistent management challenges and future directions to improve diagnostic precision, therapeutic development, and patient-centered outcomes.<\/jats:p>","DOI":"10.31083\/bjhm52377","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:59:52Z","timestamp":1790701192000},"source":"Crossref","is-referenced-by-count":0,"title":["Gastrointestinal Manifestations of Systemic Sclerosis: Screening and Management to Improve Outcomes"],"prefix":"10.31083","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2514-5316","authenticated-orcid":true,"given":"Amit","family":"Syal","sequence":"first","affiliation":[{"name":"Department of Medicine, NYU Langone Health, New York, NY 10016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishika","family":"Pasula","sequence":"additional","affiliation":[{"name":"Drexel University College of Medicine, Philadelphia, PA 19129, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiana","family":"Mortezaei","sequence":"additional","affiliation":[{"name":"Drexel University College of Medicine, Philadelphia, PA 19129, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Panayiotou","sequence":"additional","affiliation":[{"name":"Medical School, University of Cyprus, 1678 Nicosia, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeta","family":"Kumari","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7786-9714","authenticated-orcid":true,"given":"Chris","family":"Derk","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, University of Pennsylvania, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Rosendahl AH, Sch\u00f6nborn K, Krieg T. Pathophysiology of systemic sclerosis (scleroderma). The Kaohsiung Journal of Medical Sciences. 2022; 38: 187\u2013195.","DOI":"10.1002\/kjm2.12505"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Smith V, Marjenberg Z, Volkmann ER. The burden of illness of the organ manifestations of systemic sclerosis: a pragmatic, targeted review. Clinical and Experimental Rheumatology. 2025; 43: 1516\u20131526.","DOI":"10.55563\/clinexprheumatol\/ey5nhr"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Hoffmann-Vold AM, Volkmann ER. Gastrointestinal involvement in systemic sclerosis: Effects on morbidity and mortality and new therapeutic approaches. Journal of Scleroderma and Related Disorders. 2021; 6: 37\u201343.","DOI":"10.1177\/2397198319891282"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Nassar M, Ghernautan V, Nso N, Nyabera A, Castillo FC, Tu W, et al. Gastrointestinal involvement in systemic sclerosis: An updated review. Medicine. 2022; 101: e31780.","DOI":"10.1097\/MD.0000000000031780"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Kaniecki T, Hughes M, McMahan Z. Managing gastrointestinal manifestations in systemic sclerosis, a mechanistic approach. Expert Review of Clinical Immunology. 2024; 20: 603\u2013622.","DOI":"10.1080\/1744666X.2024.2320205"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. The American Journal of Gastroenterology. 2022; 117: 27\u201356.","DOI":"10.14309\/ajg.0000000000001538"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Gyawali CP, Carlson DA, Chen JW, Patel A, Wong RJ, Yadlapati RH. ACG Clinical Guidelines: Clinical Use of Esophageal Physiologic Testing. The American Journal of Gastroenterology. 2020; 115: 1412\u20131428.","DOI":"10.14309\/ajg.0000000000000734"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Pironi L, Cuerda C, Jeppesen PB, Joly F, Jonkers C, Krznari\u0107 \u017d, et al. ESPEN guideline on chronic intestinal failure in adults - Update 2023. Clinical Nutrition (Edinburgh, Scotland). 2023; 42: 1940\u20132021.","DOI":"10.1016\/j.clnu.2023.07.019"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Del Galdo F, Lescoat A, Conaghan PG, Bertoldo E, \u010coli\u0107 J, Santiago T, et al. EULAR recommendations for the treatment of systemic sclerosis: 2023 update. Annals of the Rheumatic Diseases. 2025; 84: 29\u201340.","DOI":"10.1136\/ard-2024-226430"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"McFarlane IM, Bhamra MS, Kreps A, Iqbal S, Al-Ani F, Saladini-Aponte C, et al. Gastrointestinal Manifestations of Systemic Sclerosis. Rheumatology (Sunnyvale, Calif.). 2018; 8: 235.","DOI":"10.4172\/2161-1149.1000235"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Richard N, Hudson M, Wang M, Gyger G, Proudman S, Stevens W, et al. Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality. Rheumatology (Oxford, England). 2019; 58: 636\u2013644.","DOI":"10.1093\/rheumatology\/key350"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Son HH, Moon SJ. Pathogenesis of systemic sclerosis: an integrative review of recent advances. Journal of Rheumatic Diseases. 2025; 32: 89\u2013104.","DOI":"10.4078\/jrd.2024.0129"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Volkmann ER, McMahan Z. Gastrointestinal involvement in systemic sclerosis: pathogenesis, assessment and treatment. Current Opinion in Rheumatology. 2022; 34: 328\u2013336.","DOI":"10.1097\/BOR.0000000000000899"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Sattar B, Chokshi RV. Colonic and Anorectal Manifestations of Systemic Sclerosis. Current Gastroenterology Reports. 2019; 21: 33.","DOI":"10.1007\/s11894-019-0699-0"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Voulgaris TA, Karamanolis GP. Esophageal manifestation in patients with scleroderma. World Journal of Clinical Cases. 2021; 9: 5408\u20135419.","DOI":"10.12998\/wjcc.v9.i20.5408"},{"key":"ref16","unstructured":"Appleton J. The Gut-Brain Axis: Influence of Microbiota on Mood and Mental Health. Integrative Medicine (Encinitas, Calif.). 2018; 17: 28\u201332."},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Nguyen AD, Andr\u00e9asson K, McMahan ZH, Bukiri H, Howlett N, Lagishetty V, et al. Gastrointestinal tract involvement in systemic sclerosis: The roles of diet and the microbiome. Seminars in Arthritis and Rheumatism. 2023; 60: 152185.","DOI":"10.1016\/j.semarthrit.2023.152185"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Pardali EC, Gkouvi A, Grammatikopoulou MG, Mitropoulos A, Cholevas C, Poulimeneas D, et al. Nutritional Status and Dietary Challenges in Patients with Systemic Sclerosis: A Comprehensive Review. Nutrients. 2025; 17: 3144.","DOI":"10.3390\/nu17193144"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Murray K, Wilkinson-Smith V, Hoad C, Costigan C, Cox E, Lam C, et al. Differential effects of FODMAPs (fermentable oligo-, di-, mono-saccharides and polyols) on small and large intestinal contents in healthy subjects shown by MRI. The American Journal of Gastroenterology. 2014; 109: 110\u2013119.","DOI":"10.1038\/ajg.2013.386"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Asplin JR. The management of patients with enteric hyperoxaluria. Urolithiasis. 2016; 44: 33\u201343.","DOI":"10.1007\/s00240-015-0846-5"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Sakkas LI, Simopoulou T, Daoussis D, Liossis SN, Potamianos S. Intestinal Involvement in Systemic Sclerosis: A Clinical Review. Digestive Diseases and Sciences. 2018; 63: 834\u2013844.","DOI":"10.1007\/s10620-018-4977-8"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Harrison E, Herrick AL, McLaughlin JT, Lal S. Malnutrition in systemic sclerosis. Rheumatology (Oxford, England). 2012; 51: 1747\u20131756.","DOI":"10.1093\/rheumatology\/kes160"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Cereda E, Codullo V, Klersy C, Breda S, Crippa A, Rava ML, et al. Disease-related nutritional risk and mortality in systemic sclerosis. Clinical Nutrition (Edinburgh, Scotland). 2014; 33: 558\u2013561.","DOI":"10.1016\/j.clnu.2013.08.010"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Rosato E, Gigante A, Gasperini ML, Proietti L, Muscaritoli M. Assessing Malnutrition in Systemic Sclerosis With Global Leadership Initiative on Malnutrition and European Society of Clinical Nutrition and Metabolism Criteria. JPEN. Journal of Parenteral and Enteral Nutrition. 2021; 45: 618\u2013624.","DOI":"10.1002\/jpen.1872"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"He\u0159m\u00e1nkov\u00e1 B, Oresk\u00e1 S, \u0160piritovi\u0107 M, \u0160tork\u00e1nov\u00e1 H, Komarc M, Pavelka K, et al. Sexual function and pelvic floor function in men with systemic sclerosis compared to healthy controls: a cross-sectional study. The Aging Male : the Official Journal of the International Society for the Study of the Aging Male. 2024; 27: 2336630.","DOI":"10.1080\/13685538.2024.2336630"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Volkmann ER, Andr\u00e9asson K, Smith V. Systemic sclerosis. Lancet (London, England). 2023; 401: 304\u2013318.","DOI":"10.1016\/S0140-6736(22)01692-0"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Zhang S, Zhu J, Zhu Y, Zhang X, Wu R, Li S, et al. Oral manifestations of patients with systemic sclerosis: a meta-analysis for case-controlled studies. BMC Oral Health. 2021; 21: 250.","DOI":"10.1186\/s12903-021-01603-2"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Mortazavi H, Baharvand M, Movahhedian A, Mohammadi M, Khodadoustan A. Xerostomia due to systemic disease: a review of 20 conditions and mechanisms. Annals of Medical and Health Sciences Research. 2014; 4: 503\u2013510.","DOI":"10.4103\/2141-9248.139284"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"De M\u00fagica AD, Bailey E, Loughlin A. Scleroderma: oral, maxillofacial and radiographic manifestations for dental practitioners. British Dental Journal. 2024; 236: 881\u2013886.","DOI":"10.1038\/s41415-024-7453-1"},{"key":"ref30","unstructured":"Taylor S, Miller C, Daley JO. Oral Health Considerations for Patients With Systemic Disease. StatPearls. 2025."},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Ki SH, Park TJ. Prevention and treatment of microstomia. Archives of Craniofacial Surgery. 2024; 25: 105\u2013115.","DOI":"10.7181\/acfs.2024.00276"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Hadj Said M, Foletti JM, Graillon N, Guyot L, Chossegros C. Orofacial manifestations of scleroderma. A literature review. Revue De Stomatologie, De Chirurgie Maxillo-faciale et De Chirurgie Orale. 2016; 117: 322\u2013326.","DOI":"10.1016\/j.revsto.2016.06.003"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Mar\u00edn C, D\u00edaz-de-Vald\u00e9s L, Conejeros C, Mart\u00ednez R, Niklander S. Interventions for the treatment of xerostomia: A randomized controlled clinical trial. Journal of Clinical and Experimental Dentistry. 2021; 13: e104\u2013e111.","DOI":"10.4317\/jced.57924"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Sakai F, Takizawa K, Okada-Ogawa A, Ozasa K, Noma N. Clinical Characteristics and Management of Oral Candidiasis Associated with Calcinosis, Raynaud's Phenomenon, Esophageal Dysmotility, Sclerodactyly, and Telangiectasia Syndrome. Cureus. 2024; 16: e76058.","DOI":"10.7759\/cureus.76058"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Li B, Yan J, Pu J, Tang J, Xu S, Wang X. Esophageal Dysfunction in Systemic Sclerosis: An Update. Rheumatology and Therapy. 2021; 8: 1535\u20131549.","DOI":"10.1007\/s40744-021-00382-0"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Kahrilas PJ, Sifrim D. High-resolution manometry and impedance-pH\/manometry: valuable tools in clinical and investigational esophagology. Gastroenterology. 2008; 135: 756\u2013769.","DOI":"10.1053\/j.gastro.2008.05.048"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Snyder DL, Crowell MD, Kahn A, Griffing WL, Umar S, Ramirez FC. Prevalence of Barrett's Esophagus in Female Patients With Scleroderma. The American Journal of Gastroenterology. 2021; 116: 517\u2013521.","DOI":"10.14309\/ajg.0000000000001109"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Vantanasiri K, Kamboj AK, Kisiel JB, Iyer PG. Advances in Screening for Barrett Esophagus and Esophageal Adenocarcinoma. Mayo Clinic Proceedings. 2024; 99: 459\u2013473.","DOI":"10.1016\/j.mayocp.2023.07.014"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Leiman DA, Riff BP, Morgan S, Metz DC, Falk GW, French B, et al. Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis. Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus. 2017; 30: 1\u20139.","DOI":"10.1093\/dote\/dow020"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Wani S, Zhou MJ, Sawas T, Rubenstein JH, Eluri S, Leiman DA, et al. AGA Clinical Practice Guideline on Surveillance of Barrett's Esophagus. Gastroenterology. 2025; 169: 1184\u20131231.","DOI":"10.1053\/j.gastro.2025.09.012"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Bonavina L. Individualizing the choice of surgical therapy for gastroesophageal reflux disease. Current Opinion in Gastroenterology. 2025; 41: 245\u2013250.","DOI":"10.1097\/MOG.0000000000001082"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Gyger G, Baron M. Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management. Current Rheumatology Reports. 2012; 14: 22\u201329.","DOI":"10.1007\/s11926-011-0217-3"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Santos I, Marques-Gomes C, Diz-Lopes M, Terroso G, Costa L, Miriam Ferreira R. Esophageal dysmotility in systemic sclerosis: Relationship with extra-gastrointestinal manifestations and complementary utility of thoracic imaging. Journal of Scleroderma and Related Disorders. 2025; 10: 452\u2013457.","DOI":"10.1177\/23971983251362586"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Varghese C, Zhou W, Gharibans A, Schamberg G, Van Hove S, Clarke J, et al. Autonomic Dysfunction in Gastroduodenal Disorders Evaluated Through Multimodal Non-Invasive Physiological Testing. The American Journal of Gastroenterology. 2026.  (online ahead of print)","DOI":"10.14309\/ajg.0000000000003958"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Rodolfi S, Denton CP, Ong VH. Systemic sclerosis-associated severe gastric antral vascular ectasia treated with tocilizumab:A case report and review of the literature. Journal of Scleroderma and Related Disorders. 2025; 10: NP1\u2013NP5.","DOI":"10.1177\/23971983241309570"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Billiauws L, Corcos O, Joly F. Dysmotility disorders: a nutritional approach. Current Opinion in Clinical Nutrition and Metabolic Care. 2014; 17: 483\u2013488.","DOI":"10.1097\/MCO.0000000000000095"},{"key":"ref47","unstructured":"Littlejohn J, Derk CT. In Silver RM, Denton CP (eds.) Case Studies in Systemic Sclerosis. Springer New York: USA. 2011."},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Morrisroe K, Hansen D, Stevens W, Sahhar J, Ngian GS, Hill C, et al. Gastric antral vascular ectasia in systemic sclerosis: a study of its epidemiology, disease characteristics and impact on survival. Arthritis Research & Therapy. 2022; 24: 103.","DOI":"10.1186\/s13075-022-02790-1"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Alcala-Gonzalez LG, Malagelada C, McMahan ZH. Gastrointestinal involvement in systemic sclerosis: A spotlight on small bowel involvement, complications and management. Best Practice & Research. Clinical Rheumatology. 2026; 40: 102117.","DOI":"10.1016\/j.berh.2026.102117"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Hughes M, Allanore Y, Baron M, Del Galdo F, Denton CP, Frech T, et al. Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease. The Lancet Rheumatology. 2022; 4: e795\u2013e803.","DOI":"10.1016\/S2665-9913(22)00183-7"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Staller K, Parkman HP, Greer KB, Leiman DA, Zhou MJ, Singh S, et al. AGA Clinical Practice Guideline on Management of Gastroparesis. Gastroenterology. 2025; 169: 828\u2013861.","DOI":"10.1053\/j.gastro.2025.08.004"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Broad J, Sanger GJ. The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin. British Journal of Pharmacology. 2013; 168: 1859\u20131867.","DOI":"10.1111\/bph.12077"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Tansel A, Levinthal DJ. Understanding Our Tests: Hydrogen-Methane Breath Testing to Diagnose Small Intestinal Bacterial Overgrowth. Clinical and Translational Gastroenterology. 2023; 14: e00567.","DOI":"10.14309\/ctg.0000000000000567"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Usai-Satta P, Lai M, Oppia F, Cabras F. Effects of Prokinetics on the Digestive Tract. Current Reviews in Clinical and Experimental Pharmacology. 2022; 17: 161\u2013165.","DOI":"10.2174\/2772432816666210805125813"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Suresh N, Karanth R, Cheah R, Casey J, Jayne DG, Del Galdo F. Systemic sclerosis and anorectal dysfunction: The Leeds experience. Journal of Scleroderma and Related Disorders. 2024; 9: 210\u2013215.","DOI":"10.1177\/23971983241241203"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Govoni M, Muccinelli M, Panicali P, La Corte R, Nuccio Scutellari P, Orzincolo C, et al. Colon involvement in systemic sclerosis: clinical-radiological correlations. Clinical Rheumatology. 1996; 15: 271\u2013276.","DOI":"10.1007\/BF02229706"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Kenefick NJ, Vaizey CJ, Nicholls RJ, Cohen R, Kamm MA. Sacral nerve stimulation for faecal incontinence due to systemic sclerosis. Gut. 2002; 51: 881\u2013883.","DOI":"10.1136\/gut.51.6.881"}],"container-title":["British Journal of Hospital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/BJHM\/87\/9\/10.31083\/BJHM52377","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:00:54Z","timestamp":1790701254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/BJHM\/87\/9\/10.31083\/BJHM52377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":57,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"alternative-id":["S1759-7390(26)03917-0"],"URL":"https:\/\/doi.org\/10.31083\/bjhm52377","relation":{},"ISSN":["1750-8460","1759-7390"],"issn-type":[{"value":"1750-8460","type":"print"},{"value":"1759-7390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"article-number":"52377"}}